Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028639 · ClinicalTrials.gov registry record · Phase 2
PS-341 in Treating Women With Metastatic Breast Cancer
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00028639 is a Phase 2 study that has completed, run by Northwestern University.
The verdict
NCT00028639, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth. PURPOSE: Phase II trial to study the effectiveness of PS-341 in treating women who have metastatic breast cancer.
Interventions
- DRUG bortezomib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-08 |
| Est. Completion | 2003-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00028639
The ClinicalTrials.gov registry entry for NCT00028639 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bortezomib is the first listed.
NCT00028639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00028639 about?
NCT00028639 is a clinical study titled "PS-341 in Treating Women With Metastatic Breast Cancer". RATIONALE: PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth. PURPOSE: Phase II trial to study the effectiveness of PS-341 in treating women who have metastatic breast cancer.
What is the current status of trial NCT00028639?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-08. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00028639?
The interventions under investigation include: bortezomib (DRUG).
Who is sponsoring clinical trial NCT00028639?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.